Hazel Hunt - Feb 11, 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Scientific Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Hazel Hunt
Stock symbol
CORT
Transactions as of
Feb 11, 2025
Transactions value $
-$5,307,837
Form type
4
Date filed
2/13/2025, 08:20 PM
Previous filing
Aug 5, 2024
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $494K +150K +126.5% $3.29 269K Feb 11, 2025 Direct
transaction CORT Common Stock Tax liability -$5.8M -85.2K -31.71% $68.11 183K Feb 11, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock Option (right to buy) Options Exercise $0 -150K -100% $0.00 0 Feb 11, 2025 Common Stock 150K $3.29 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 18, 2025.
F2 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.